Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review
暂无分享,去创建一个
A. Briganti | S. Shariat | P. Karakiewicz | D. Enikeev | M. Abufaraj | B. Pradère | V. Schuettfort | H. Mostafaei | G. Ploussard | R. Sari Motlagh | K. Mori | S. Katayama | N. Grossmann | E. Laukhtina | F. Quhal
[1] T. Ahlering,et al. Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID‐19) pandemic: an international accelerated consensus statement , 2020, BJU international.
[2] D. Patt,et al. Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors , 2020, JCO clinical cancer informatics.
[3] T. Skolarus,et al. The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future , 2020, European Urology.
[4] C. Iselin,et al. Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic , 2020, World Journal of Urology.
[5] S. Pridgeon,et al. Delay to radical prostatectomy: Who, why and does it matter? , 2020 .
[6] A. Kural,et al. Management of prostate cancer patients during COVID-19 pandemic , 2020, Prostate Cancer and Prostatic Diseases.
[7] R. Campi,et al. A Global Survey on the Impact of COVID-19 on Urological Services , 2020, European Urology.
[8] V. Margulis,et al. Active Surveillance for Intermediate-Risk Prostate Cancer: Systematic Review and Meta-analysis of Current Protocols and Outcomes. , 2020, Clinical genitourinary cancer.
[9] T. Powles,et al. Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic☆ , 2020, European Urology.
[10] A. George,et al. Delayed Radical Prostatectomy is Not Associated with Adverse Oncological Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic. , 2020, The Journal of urology.
[11] M. Babjuk,et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era☆ , 2020, European Urology.
[12] K. Zorn,et al. Impact of surgical wait times during summer months on the oncological outcomes following robotic-assisted radical prostatectomy: 10 years’ experience from a large Canadian academic center , 2020, World Journal of Urology.
[13] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[14] Ashutosh,et al. Management of patients who opt for radical prostatectomy during the COVID-19 pandemic: An International Accelerated Consensus Statement. , 2020 .
[15] M. Cooperberg,et al. Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance. , 2019, The Journal of urology.
[16] R. Thompson,et al. Impact of time from biopsy to surgery on complications, functional and oncologic outcomes following radical prostatectomy , 2019, International braz j urol : official journal of the Brazilian Society of Urology.
[17] K. Trpkov,et al. The effect of time from biopsy to radical prostatectomy on adverse pathologic outcomes , 2019, Research and reports in urology.
[18] A. Partin,et al. Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate‐risk to very‐high‐risk clinically localised prostate cancer , 2019, BJU international.
[19] M. Savaş,et al. Impact of Delay from Biopsy to Surgery on the Rate of Adverse Pathologic and Oncologic Outcomes for Clinically Localized Prostate Cancer , 2018, The Bulletin of Urooncology.
[20] S. Fosså,et al. Is time from diagnosis to radical prostatectomy associated with oncological outcomes? , 2018, World Journal of Urology.
[21] J. Hugosson,et al. Long‐Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance , 2018, The Journal of urology.
[22] E. Faria,et al. Time between diagnosis and surgical treatment on pathological and clinical outcomes in prostate cancer: does it matter? , 2018, World Journal of Urology.
[23] F. Montorsi,et al. Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: Can surgery be postponed safely? , 2017, Urologic oncology.
[24] F. Saad,et al. Does surgical delay for radical prostatectomy affect biochemical recurrence? A retrospective analysis from a Canadian cohort , 2017, World Journal of Urology.
[25] P. Carroll,et al. Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer. , 2015, European urology.
[26] K. Badani,et al. Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomes , 2015, The Prostate.
[27] M. Terris,et al. Delayed radical prostatectomy for intermediate‐risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database , 2013, The Prostate.
[28] J. McKiernan,et al. Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis , 2012, BJU international.
[29] Kirsten L. Greene,et al. Outcomes of active surveillance for men with intermediate-risk prostate cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] J. Ioannidis,et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].